Conrad Pharma SRL
2.5 FTEThe score of Conrad Pharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +26 % Total assets +45 % Headcount (avg FTE) +32 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Conrad Pharma's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 28 Aug 2026
- Year ended 31 Dec 2024filed on 29 Aug 2025
- Year ended 31 Dec 2023filed on 12 Jul 2024
- Year ended 31 Dec 2022filed on 05 Jul 2023
- Year ended 31 Dec 2021filed on 25 Aug 2022
Conrad Pharma's financial analysis
- Solvency22.6%sector median: 44.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Conrad Pharma
Conrad Pharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0536.875.697
- VAT number
- BE0536875697
- Peppol
- Registered · 0208:0536875697 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 23 Jul 2013
- Registered office
- 9700 Oudenaarde
- Size
- Micro · 2.5 FTE
- Latest accounts
- 2025 · filed on 28 Aug 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Conrad Pharma (SRL) has been based in Oudenaarde since 2013, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 199,229 € and equity of €1.13m; its revenue is not published. With 2.5 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 22.6%, below the median of its sector (44.2%).
Companies similar to Conrad Pharma
Companies in the same business, of comparable size and area, outside its group.
- Yascare Retail sale of pharmaceutical products Uccle · balance sheet 34,424 €
- Apotheek Greet Vanmeirhaeghe Retail sale of pharmaceutical products Kluisbergen · balance sheet €2.30m
- Pharma Fidelmed Retail sale of pharmaceutical products Ghent · balance sheet €2.04m
- Wille Sandrina Retail sale of pharmaceutical products Grimbergen · balance sheet €4.26m
- King Kong Retail sale of pharmaceutical products Bertem · balance sheet €4.24m
- Gerardiphar Retail sale of pharmaceutical products Geraardsbergen · balance sheet 931,701 €
- Codema Pharma Retail sale of pharmaceutical products Brussels · balance sheet 375,959 €
- Offiplant Retail sale of pharmaceutical products Lessines · balance sheet €3.17m
Frequently asked questions about Conrad Pharma
What is the revenue of Conrad Pharma?
Conrad Pharma files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Conrad Pharma?
In Belgium, the VAT number is the company number prefixed with BE: BE0536875697 for Conrad Pharma, if the company is VAT-registered. Its company number (CBE) is 0536.875.697.
Where is the registered office of Conrad Pharma?
According to the CBE register, the registered office of Conrad Pharma is in 9700 Oudenaarde.
What is the equity of Conrad Pharma?
At the close of the 2025 financial year, the equity of Conrad Pharma amounts to 1,133,149 €, a solvency of 22.6% of total assets.
How many people work at Conrad Pharma?
2.5 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Conrad Pharma?
The register lists 4 active mandates at Conrad Pharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Conrad Pharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →